Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVAH NYSE:CON NASDAQ:PRVA NASDAQ:SGRY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVAHAveanna Healthcare$3.95-0.4%$4.83$2.61▼$6.19$765.73M1.98375,085 shs112,411 shsCONConcentra Group Holdings Parent$20.07+2.1%$20.93$18.89▼$24.81$2.57BN/A771,099 shs820,899 shsPRVAPrivia Health Group$19.70-0.1%$22.06$16.47▼$26.09$2.40B0.82815,682 shs367,396 shsSGRYSurgery Partners$22.36+5.2%$22.28$18.87▼$33.97$2.87B1.91.37 million shs1.70 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVAHAveanna Healthcare0.00%0.00%-21.12%-11.41%-9.79%CONConcentra Group Holdings Parent0.00%+0.72%-6.87%-8.96%+1,969,999,900.00%PRVAPrivia Health Group0.00%+0.46%-10.45%-15.09%-3.71%SGRYSurgery Partners0.00%-4.75%-3.14%-1.39%-33.60%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVAHAveanna Healthcare2.411 of 5 stars3.13.00.00.03.22.50.0CONConcentra Group Holdings Parent3.154 of 5 stars3.50.02.50.03.00.01.3PRVAPrivia Health Group4.0347 of 5 stars3.54.00.00.02.83.31.9SGRYSurgery Partners2.6722 of 5 stars3.41.00.00.02.80.02.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVAHAveanna Healthcare 2.17Hold$5.2533.08% UpsideCONConcentra Group Holdings Parent 3.00Buy$28.5042.04% UpsidePRVAPrivia Health Group 3.00Buy$28.3844.08% UpsideSGRYSurgery Partners 2.70Moderate Buy$33.3349.11% UpsideCurrent Analyst Ratings BreakdownLatest AVAH, SGRY, CON, and PRVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/28/2025SGRYSurgery PartnersBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$28.007/21/2025AVAHAveanna HealthcareJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$6.25 ➝ $6.007/16/2025AVAHAveanna HealthcareTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$6.00 ➝ $5.007/9/2025PRVAPrivia Health GroupEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$30.00 ➝ $28.007/2/2025AVAHAveanna HealthcareBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageEqual Weight$5.505/28/2025PRVAPrivia Health GroupJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $32.005/27/2025PRVAPrivia Health GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$23.00 ➝ $24.005/27/2025SGRYSurgery PartnersBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$25.00 ➝ $24.005/9/2025AVAHAveanna HealthcareUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSell ➝ Sell$4.50 ➝ $5.004/28/2025PRVAPrivia Health GroupJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$29.00 ➝ $29.00(Data available from 7/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVAHAveanna Healthcare$2.02B0.38$0.16 per share24.15($0.64) per share-6.16CONConcentra Group Holdings Parent$1.93B1.33$1.89 per share10.64$2.20 per share9.12PRVAPrivia Health Group$1.74B1.38$0.18 per share109.21$5.70 per share3.46SGRYSurgery Partners$3.17B0.90$1.97 per share11.35$25.15 per share0.89Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVAHAveanna Healthcare-$10.93M$0.02196.25∞N/A0.26%-15.16%1.14%8/7/2025 (Estimated)CONConcentra Group Holdings Parent$166.54M$1.3414.9615.431.768.09%29.94%6.31%8/7/2025 (Confirmed)PRVAPrivia Health Group$14.39M$0.12164.1872.963.150.87%2.32%1.38%8/7/2025 (Estimated)SGRYSurgery Partners-$168.10M-$1.53N/A27.60N/A-6.10%2.41%0.99%8/5/2025 (Estimated)Latest AVAH, SGRY, CON, and PRVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025AVAHAveanna Healthcare$0.04N/AN/AN/A$535.34 millionN/A8/7/2025Q2 2025CONConcentra Group Holdings Parent$0.37N/AN/AN/A$537.36 millionN/A8/7/2025Q2 2025PRVAPrivia Health Group$0.05N/AN/AN/A$466.97 millionN/A8/5/2025Q2 2025SGRYSurgery Partners$0.16N/AN/AN/A$816.96 millionN/A5/12/2025Q1 2025SGRYSurgery Partners$0.08$0.04-$0.04-$0.30$777.77 million$776.00 million5/7/2025Q1 2025CONConcentra Group Holdings Parent$0.31$0.32+$0.01$0.30$496.06 million$500.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVAHAveanna HealthcareN/AN/AN/AN/AN/ACONConcentra Group Holdings Parent$0.251.25%N/A18.66%N/APRVAPrivia Health GroupN/AN/AN/AN/AN/ASGRYSurgery PartnersN/AN/AN/AN/AN/ALatest AVAH, SGRY, CON, and PRVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/8/2025CONConcentra Group Holdings Parentquarterly$0.06251.2%5/20/20255/20/20255/29/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVAHAveanna HealthcareN/A1.051.05CONConcentra Group Holdings Parent5.181.101.10PRVAPrivia Health GroupN/A1.881.88SGRYSurgery Partners1.091.891.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVAHAveanna Healthcare87.96%CONConcentra Group Holdings ParentN/APRVAPrivia Health Group94.48%SGRYSurgery PartnersN/AInsider OwnershipCompanyInsider OwnershipAVAHAveanna Healthcare7.00%CONConcentra Group Holdings Parent6.60%PRVAPrivia Health Group10.70%SGRYSurgery Partners2.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVAHAveanna Healthcare33,500195.09 million181.44 millionOptionableCONConcentra Group Holdings Parent11,250128.17 million119.71 millionN/APRVAPrivia Health Group1,140121.92 million108.88 millionOptionableSGRYSurgery Partners15,000128.16 million125.21 millionOptionableAVAH, SGRY, CON, and PRVA HeadlinesRecent News About These CompaniesSurgery Partners (NASDAQ:SGRY) Earns Buy Rating from Analysts at Bank of AmericaJuly 28 at 10:14 AM | marketbeat.comFinancial Review: Danaher (NYSE:DHR) vs. Surgery Partners (NASDAQ:SGRY)July 28 at 2:48 AM | americanbankingnews.comSurgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Recommendation of "Moderate Buy" from AnalystsJuly 27 at 2:25 AM | marketbeat.comVictory Capital Management Inc. Sells 371,195 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)July 23, 2025 | marketbeat.comSegall Bryant & Hamill LLC Has $3.53 Million Stake in Surgery Partners, Inc. (NASDAQ:SGRY)July 19, 2025 | marketbeat.comSurgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call ...July 18, 2025 | gurufocus.comSurgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call ...July 18, 2025 | gurufocus.comSurgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call DetailsJuly 18, 2025 | globenewswire.com18,817 Shares in Surgery Partners, Inc. (NASDAQ:SGRY) Bought by Teacher Retirement System of TexasJuly 18, 2025 | marketbeat.comWhy Surgery Partners (SGRY) Stock Is Trading Up TodayJuly 16, 2025 | msn.comSurgery Partners, Inc. (SGRY): A Bull Case TheoryJuly 15, 2025 | msn.com1 Healthcare Stock to Keep an Eye On and 2 to Be Wary OfJuly 7, 2025 | finance.yahoo.comCIBRA Capital Ltd Makes New Investment in Surgery Partners, Inc. (NASDAQ:SGRY)July 2, 2025 | marketbeat.comSurgery Partners, Inc. (NASDAQ:SGRY) Given Consensus Rating of "Moderate Buy" by BrokeragesJuly 2, 2025 | marketbeat.comSGRY Surgery Partners, Inc. - Seeking AlphaJune 27, 2025 | seekingalpha.comSurgery Partners says no to Bain — here’s the bigger pictureJune 24, 2025 | beckersasc.comBRSI Alert: Surgery Partners (SGRY) Now OversoldJune 19, 2025 | nasdaq.comSurgery Partners: The Plunge Doesn't Justify An UpgradeJune 18, 2025 | seekingalpha.comSurgery Partners stock falls after concluding discussions with Bain CapitalJune 18, 2025 | investing.comSurgery Partners rejects Bain Capital's acquisition offer, opts to remain publicJune 18, 2025 | bizjournals.comSurgery Partners declines Bain Capital bid, stays publicly listed companyJune 18, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendHow a Government Loan Changes the Game for Plug PowerBy Jeffrey Neal Johnson | July 4, 2025View How a Government Loan Changes the Game for Plug Power3 Catalysts Driving Plug Power’s Turnaround CaseBy Jeffrey Neal Johnson | July 18, 2025View 3 Catalysts Driving Plug Power’s Turnaround CaseD-Wave Is Rising Again Despite Dilution—What’s the Deal?By Nathan Reiff | July 7, 2025View D-Wave Is Rising Again Despite Dilution—What’s the Deal?Do They Know Something? Insiders & Congress Buy UnitedHealthBy Brian O'Connell | July 9, 2025View Do They Know Something? Insiders & Congress Buy UnitedHealthAVAH, SGRY, CON, and PRVA Company DescriptionsAveanna Healthcare NASDAQ:AVAH$3.94 -0.02 (-0.38%) As of 03:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.Concentra Group Holdings Parent NYSE:CON$20.07 +0.41 (+2.06%) As of 03:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.Privia Health Group NASDAQ:PRVA$19.70 -0.01 (-0.05%) As of 03:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.Surgery Partners NASDAQ:SGRY$22.36 +1.10 (+5.15%) As of 03:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Reasons Tesla's Post-Earnings Hangover Looks Like a Buy Taiwan Semiconductor Could Boom on This AI Action Plan Chevron's New Upside Catalyst in Venezuelan Oil Rights T-Mobile Earnings Show You Why This Is a Stock to Hold American Airlines Earnings Miss, But Bulls Aren’t Backing Off PEGA Surges 14%: There's Still Time to Ride This GenAI Innovator Meta's Q2 Earnings: Key Areas Investors Must Pay Attention To Intel's Turnaround Gains Credibility With Strong Q2 Report Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
